Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박소정 | - |
dc.date.accessioned | 2020-03-23T16:30:20Z | - |
dc.date.available | 2020-03-23T16:30:20Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.other | OAK-26580 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/253622 | - |
dc.description.abstract | Tumor-derived exosomes (TEXs) contain enriched miRNAs that act as novel non-invasive biomarkers for cancer diagnosis and play a role in cancer progression. We investigated the exosomal miRNAs that affect cancer progression in non-small cell lung cancer (NSCLC) and identified the specific molecules involved. We identified that specific miRNAs in NSCLC cell-released exosomes can modulate angiogenesis, among which miR-619-5p was the most potent inducer. RCAN1.4 was identified as a target of miR-619-5p and its suppression promoted angiogenesis. Furthermore, the suppression of RCAN1.4 induced cell proliferation and metastasis in NSCLC cells. In patients with NSCLC, the level of RCAN1.4 expression was significantly lower, and that of miR-619-5p significantly higher, in tumor than normal lung tissues. miR-619-5p expression was higher than normal in exosomes isolated from the plasma of NSCLC patients. Finally, hypoxic conditions induced miR-619-5p upload into NSCLC cell-derived exosomes. Our findings indicate that exosomal miR-619-5p promotes the growth and metastasis of NSCLCs by regulating RCAN1.4 and can serve as a diagnostic indicator for these lung cancers. © 2020 Elsevier B.V. | - |
dc.language | English | - |
dc.publisher | Elsevier Ireland Ltd | - |
dc.subject | Exosomal miRNAs | - |
dc.subject | Exosome | - |
dc.subject | Non-small cell lung cancer | - |
dc.subject | RCAN1 | - |
dc.subject | Tumor growth | - |
dc.title | Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4 | - |
dc.type | Article | - |
dc.relation.volume | 475 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SCOPUS | - |
dc.relation.startpage | 2 | - |
dc.relation.lastpage | 13 | - |
dc.relation.journaltitle | Cancer Letters | - |
dc.identifier.doi | 10.1016/j.canlet.2020.01.023 | - |
dc.identifier.wosid | WOS:000521111300002 | - |
dc.identifier.scopusid | 2-s2.0-85078835670 | - |
dc.author.google | Kim D.H. | - |
dc.author.google | Park S. | - |
dc.author.google | Kim H. | - |
dc.author.google | Choi Y.J. | - |
dc.author.google | Kim S.Y. | - |
dc.author.google | Sung K.J. | - |
dc.author.google | Sung Y.H. | - |
dc.author.google | Choi C.-M. | - |
dc.author.google | Yun M. | - |
dc.author.google | Yi Y.-S. | - |
dc.author.google | Lee C.W. | - |
dc.author.google | Kim S.-Y. | - |
dc.author.google | Lee J.C. | - |
dc.author.google | Rho J.K. | - |
dc.contributor.scopusid | 박소정(57205588025) | - |
dc.date.modifydate | 20230125114338 | - |